Tandem Diabetes Care Inc (TNDM) Files Form 4 Insider Selling : John F Sheridan Sells 2,000 Shares

Tandem Diabetes Care Inc (TNDM): John F Sheridan , EVP, CHIEF OPERATING OFFICER of Tandem Diabetes Care Inc sold 2,000 shares on May 2, 2016. The Insider selling transaction was reported by the company on May 2, 2016 to the Securities and Exchange Commission. The shares were sold at $10.61 per share for a total value of $21,212.60 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 22, 2016, John F Sheridan (EVP, CHIEF OPERATING OFFICER) sold 2,000 shares at $10.00 per share price.On Aug 4, 2015, Howard E Jr Greene (director) sold 20,000 shares at $12.70 per share price.

Tandem Diabetes Care Inc: On Wednesday, Apr 27, 2016 heightened volatility was witnessed in Tandem Diabetes Care Inc which led to swings in the share price. The shares opened for trading at $10.35 and hit $10.48 on the upside , eventually ending the session at $10.39, with a gain of 1.07% or 0.11 points. The heightened volatility saw the trading volume jump to 82,930 shares. The 52-week high of the share price is $14.01 and the company has a market cap of $315 M . The 52-week low of the share price is at $6.59.

Tandem Diabetes Care Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.Tandem Diabetes Care Inc is Downgraded by BofA/Merrill to Underperform. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Mar 24, 2016.

Tandem Diabetes Care Inc. is a medical device company engaged in designing developing and commercializing products for people with insulin-dependent diabetes. The Company’s products include t:slim Insulin Delivery System (t:slim) and t:flex Insulin Delivery System (t:flex). The t:slim consists of the t:slim pump its 300-unit disposable insulin cartridge and an infusion set. The t:flex consists of the t:flex pump its 480-unit disposable insulin cartridge and an infusion set. The Company’s technology platform features Micro-Delivery Technology a miniaturized pumping mechanism which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism.

Leave a Reply

Tandem Diabetes Care Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Tandem Diabetes Care Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.